Sign in
4

Changes in Ownership

Cytosorbents Corp Filed Acc 0001144204-15-059931

Director sold 6,774 shares at $6.22 ($42,122)

  • Director acquired 6,774 shares (option exercise)

From the SEC's structured data for this filing

Trades in this filing

Table I: Non-derivative

Insider Date Transaction Shares Price Value Owned after D/I
Kraus Al Director 2015-10-15 Option exercise +6,774 $0.88 $5,927 62,520 D: show line 1 in the form
Kraus Al Director 2015-10-15 Sale −6,774 $6.22 $42,122 55,746 D: show line 2 in the form
Open-market sales · 6,774 sh · avg $6.22 · $42,122

Table II: Derivative

Insider Date Transaction Shares Price Value Owned after D/I
Kraus Al Director 2015-10-15 Option exercise · Stock Option −10,000 0 D: show line 3 in the form
Loading xslF345X03/v422421_4.xml…